International Journal of Molecular Medical Science, 2025, Vol.15, No.6, 287-297 http://medscipublisher.com/index.php/ijmms 296 Mishra S., Modak A., Awasthi M., Sobha A., and Sreekumar E., 2025, Ponatinib and other clinically approved inhibitors of Src and Rho-A kinases abrogate dengue virus serotype 2- induced endothelial permeability, Virulence, 16(1): 2489751. https://doi.org/10.1080/21505594.2025.2489751 Moallemi S., Lloyd A., and Rodrigo C., 2023, Early biomarkers for prediction of severe manifestations of dengue fever: a systematic review and a meta-analysis, Scientific Reports, 13(1): 17485. https://doi.org/10.1038/s41598-023-44559-9 Moallemi S., Tedla N., Sigera C., Weeratunga P., Fernando D., Rajapakse S., Lloyd A., and Rodrigo C., 2025, Early circulating biomarkers to predict plasma leakage in dengue fever, The Journal of Infection, 90(2): 106401. https://doi.org/10.1016/j.jinf.2024.106401 Modak A., Mishra S., Awasthi M., Aravind A., Singh S., and Sreekumar E., 2023, Fingolimod (FTY720) an FDA‐approved sphingosine 1‐phosphate (S1P) receptor agonist restores endothelial hyperpermeability in cellular and animal models of dengue virus serotype 2 infection, IUBMB Life, 76: 267-285. https://doi.org/10.1002/iub.2795 Nie Q., Li M., Liang Q., Ren J., Li T., Peng W., Luo C., Mo X., Ma X., Li J., and Jiang K., 2025, Clinical features and laboratory indicators of dengue infection in China: a retrospective study of adult patients in a hospital of traditional Chinese medicine, Frontiers in Medicine, 12: 1624554. https://doi.org/10.3389/fmed.2025.1624554 Pal P., Bathia J., and Goud C., 2024, Is severe dengue a cytokine storm syndrome?, Indian Pediatrics, 61(11): 1059-1064. https://doi.org/10.1007/s13312-024-3318-6 Paul J., Azmal M., Alam T., Talukder O., and Ghosh A., 2025, Comprehensive analysis of intervention and control studies for the computational identification of dengue biomarker genes, PLOS Neglected Tropical Diseases, 19(3): e0012914. https://doi.org/10.1371/journal.pntd.0012914 Prajapati H., Kumar V., Mittal G., and Saxena Y., 2024, Pro-and anti-inflammatory cytokines signatures at different severity of dengue infection, Journal of Family Medicine and Primary Care, 13: 1975-1982. https://doi.org/10.4103/jfmpc.jfmpc_1576_23 Samune Y., Saito A., Sasaki T., Koketsu R., Srimark N., Phadungsombat J., Yokoyama M., Kotani O., Sato H., Yamanaka A., Haga S., Okamoto T., Kurosu T., Nakayama E., and Shioda T., 2024, Genetic regions affecting the replication and pathogenicity of dengue virus type 2, PLOS Neglected Tropical Diseases, 18(1): e0011885. https://doi.org/10.1371/journal.pntd.0011885 Sarwar M., Ashraf R., Sohail H., Majeed R., Khan Z., Rehan M., Arif S., Kamil N., and Ali R., 2025, Oxidized HDL as a novel predictive biomarker in conjunction with selected inflammatory variables in severe dengue fever patients from Lahore Pakistan, Current molecular Medicine, 25(8): 1087-1094. https://doi.org/10.2174/0115665240365589250519221441 Shabbir M., and Linh D., 2024, Immune response to dengue virus infection: mechanisms and implications, Pakistan Armed Forces Medical Journal, 74(6):1763. https://doi.org/10.51253/pafmj.v74i6.12887 Shetty R., Bhat C., Chennakeshava D., and R D., 2025, Profile of immunomodulation in children with severe dengue admitted in PICU, Indian Journal of Critical Care Medicine, 29(Suppl 1): S139. https://doi.org/10.5005/jaypee-journals-10071-24933.101 Sinha S., Singh K., Kumar Y., Roy R., Phadnis S., Meena V., Bhattacharyya S., and Verma B., 2024, Dengue virus pathogenesis and host molecular machineries, Journal of Biomedical Science, 31(1): 43. https://doi.org/10.1186/s12929-024-01030-9 Sivasubramanian S., Mohandas S., Gopalan V., Raj V., Govindan K., Varadarajan P., Kaveri K., and Ramkumar K., 2022, The utility of inflammatory and endothelial factors in the prognosis of severe dengue, Immunobiology, 227(6): 152289. https://doi.org/10.1016/j.imbio.2022.152289 Sun D., Lien T., and Chang H., 2025, Virus-induced pathogenic antibodies: lessons from long COVID and dengue hemorrhage fever, International Journal of Molecular Sciences, 26(5): 1898. https://doi.org/10.3390/ijms26051898 Tejo A., Hamasaki D., Menezes L., and Ho Y., 2023, Severe dengue in the intensive care unit, Journal of Intensive Medicine, 4: 16-33. https://doi.org/10.1016/j.jointm.2023.07.007 Teramoto T., 2025, Dual EMCV-IRES-integrated dengue virus can express an exogenous gene and cellular Mdm2 integration suppresses the dengue viral replication, Frontiers in Microbiology, 16: 1533062. Vairaperumal T., Lee P., and Liu P., 2025, Portable point-of-care diagnosis platforms and emerging predictive biomarkers for rapid detection of severe dengue viral infection, ACS Sensors, 10: 3302-3316. https://doi.org/10.1021/acssensors.5c00263 Yoo J., Shporn O., and Sklan E., 2025, Dysregulated immune cell responses in severe dengue pathogenesis, Frontiers in Immunology, 16: 1600999. https://doi.org/10.3389/fimmu.2025.1600999 Yang C., Lee I., Chen Y., Huang W., Hsu J., Tai C., Huang C., Lin C., and Chen Y., 2025, Prognostic factors in severe dengue patients: a multi-center retrospective cohort study, PLOS Neglected Tropical Diseases, 19(1): e0012846. https://doi.org/10.1371/journal.pntd.0012846 Yuan K., Chen Y., Zhong M., Lin Y., and Liu L., 2022, Risk and predictive factors for severe dengue infection: a systematic review and meta-analysis, PLoS ONE, 17(4): e0267186.
RkJQdWJsaXNoZXIy MjQ4ODYzNA==